OBP-1705

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOBP-1705
Drug Alias NameOBP-1705
ClassificationOther
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncolys Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncolys Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A